Drug recall · March 21, 2018
Valganciclovir Tablets recall
Why: Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60
- Lots / codes
Lot #s VGC17040 & VGC17041, EXP 07/2019
- Quantity
- 1764 60-count bottles
- Company
- Hetero Labs Limited Unit V, Jadcherla Mandal, Mahaboob Nagar
- Distribution
- NJ and then distributed Nationwide in the USA
- Initiated
- February 13, 2018 · Voluntary: Firm initiated
- Classified
- March 16, 2018
- Reported
- March 21, 2018
- Ended
- February 18, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valganciclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.